A nurse-led vascular access team at the Sunshine Coast University Hospital (SCUH) has implemented an innovative bedside service when applying peripherally inserted central catheter (PICC) line treatment. CTS ™ allows for magnetic tracking of the PICC line during insertion and confirmation of the final tip location using and echocardiogram (ECG). This has resulted in most patients not requiring Chest Xray or fluoroscopy.
The bedside ECG method was trialled in July 2015 and implemented in February 2016. The 2016 service was offered three days a week and employed one nurse.
Today it is a seven-day a week service at SCUH, consisting of one clinical nurse consultant and 2.5 FTE clinical nurses during business hours.
Nurse-led bedside PICC service
Initiative Type
Service Improvement
Status
Deliver
Added
Last updated
Summary
Key dates
Jan 2016
Mar 2023
Implementation sites
Sunshine Coast University Hospital
Aim
To improve catheter placement, patient satisfaction and achieve economical benefits utilising the Sherlock 3CG ™ Tip confirmation system (TCS)
Benefits
• patient satisfaction improved (at the bedside)
• efficient - no transfers to Radiology
• no exposure to radiation
• cost effective
• PICC can be used immediately
• mobile (can travel between facilities with minimal equipment)
Background
Prior to 2009 all PICC insertions were limited to the medical imaging (MI) department using XRay and or Fluro as confirmation. A Hospital in the Home service was introduced in mid-2009 and at that time the MI department did not have the capacity to insert the increased number of PICCs. This led to the introduction of a Nurse-led bedside service to assist with the predicted increase of PICCs.
The Nurse-led PICC service model was 'blind bedside placement' - a catheter pushed into the vein at a set distance according to anatomical measurement taken externally, followed by a confirmatory XRay.
Often due to pressures there were delays waiting for logistics and medical officers to review X rays, which then delayed treatments and inhibited flow e.g. hospital in the home programmes, total parenteral nutrition (TPN)_ and chemotherapy.
SCHHS has always had the option of both Fluro and blind methods. The Vascular Access Surveillance and Education service (VASE) utilised the blind method when the service commenced in 2009. Difficult insertions and certain patient populations e.g., Cystic Fibrosis are referred to Fluro directly.
VASE trialled the Sherlock 3CG TCS™ in 2015 with favourable results which included accurate tip placement, decreased malposition’s, time to treatment increased, patient satisfaction and improved patient flow.
The system allows magnetic tracking of the PICC during insertion and confirmation of the final location using ECG.
